Page last updated: 2024-11-06

aspartyl-phenylalanine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Aspartyl-phenylalanine, also known as aspartame, is an artificial non-saccharide sweetener about 180 times sweeter than sucrose. It is commonly used in diet foods and beverages. It is synthesized by reacting aspartic acid and phenylalanine. Aspartame is widely studied due to its potential health effects, including its role in brain function, its impact on blood sugar levels, and its potential association with certain types of cancer.'

aspartyl-phenylalanine: metabolite of aspartame; may inhibit angiotensin converting enzyme; RN given refers to all (L)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID93078
CHEMBL ID170376
CHEBI ID73830
SCHEMBL ID135366
MeSH IDM0131578

Synonyms (43)

Synonym
aspartyl-phenylalanine
ASP-PHE ,
asp-phe, 96%
CHEMBL170376 ,
chebi:73830 ,
l-a-aspartyl-l-phenylalanine
aspartylphenylalanine
einecs 236-557-3
n-l-alpha-aspartyl-3-phenyl-l-alanine
n-l-alpha-aspartyl-l-phenylalanine
13433-09-5
l-alpha-asp-l-phe
l-alpha-aspartyl-l-phenylalanine
l-asp-l-phe
l-aspartyl-l-phenylalanine
demethylaspartame
h-asp-phe-oh
AKOS022180930
SCHEMBL135366
YZQCXOFQZKCETR-UWVGGRQHSA-N
alpha-l-aspartyl-l-phenylalanine
(s)-3-amino-4-((s)-1-carboxy-2-phenylethylamino)-4-oxobutanoic acid
bdbm50049759
(s)-3-amino-4-(((s)-1-carboxy-2-phenylethyl)amino)-4-oxobutanoic acid
l-aspartyl-l-phenylalanine; aspartame imp. b (ep); aspartame impurity b
n-l-aspartyl-l-phenylalanine
a-l-aspartyl-l-phenylalanine
a-aspartylphenylalanine
3-amino-n-(carboxyphenethyl)-succinamic acid stereoisomer
3-amino-n-(a-carboxyphenethyl)-succinamic acid stereoisomer
n-l-a-aspartyl-l-phenylalanine
Q27144148
F10617
AS-46818
n-(2-amino-3-carboxy-1-hydroxypropylidene)phenylalanine
DTXSID20928570
AMY22291
(3s)-3-amino-4-[[(1s)-1-carboxy-2-phenylethyl]amino]-4-oxobutanoic acid
l-aspartyl-l-phenylalanine hydrochloride
13433-09-5 (free amine)
n-l-alpha-aspartyl-l-phenylalanine hydrochloride
l-alpha-aspartyl-l-phenylalanine hydrochloride
CS-0044366
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
human xenobiotic metaboliteAny human metabolite produced by metabolism of a xenobiotic compound in humans.
human blood serum metaboliteAny metabolite (endogenous or exogenous) found in human blood serum samples.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
dipeptideAny molecule that contains two amino-acid residues connected by peptide linkages.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID235568Quality of taste by acting at receptor site; Bitter1986Journal of medicinal chemistry, Jun, Volume: 29, Issue:6
Structure-taste correlation of L-aspartyl dipeptides using SIMCA method.
AID500815Activation of nitrogen-starved wild type sigma1278b yeast Gap1-mediated amino acid uptake at 5 mM after 60 secs relative to L-citrulline2009Nature chemical biology, Jan, Volume: 5, Issue:1
Transport and signaling via the amino acid binding site of the yeast Gap1 amino acid transceptor.
AID500817Competitive inhibition of nitrogen-starved wild type sigma1278b yeast Gap1-mediated amino acid uptake at 5 mM after 60 secs relative to L-citrulline2009Nature chemical biology, Jan, Volume: 5, Issue:1
Transport and signaling via the amino acid binding site of the yeast Gap1 amino acid transceptor.
AID1183271Inhibition of ACE (unknown origin)2014European journal of medicinal chemistry, Sep-12, Volume: 84CoMFA and CoMSIA analysis of ACE-inhibitory, antimicrobial and bitter-tasting peptides.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (31.25)18.7374
1990's3 (18.75)18.2507
2000's5 (31.25)29.6817
2010's2 (12.50)24.3611
2020's1 (6.25)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.00

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.00 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.41 (4.65)
Search Engine Demand Index30.68 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (31.00)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.88%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (94.12%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]